NCT07812493

Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-09-01Est. Completion: 2028-09-01

Enrollment target: 24 participants

Locations

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China

Contact

Chronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia

Background: Chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) are diseases in which the body makes to…

Bethesda, United StatesEst. completion Dec 1, 2030

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

The purpose of this study is to evaluate the efficacy and safety of tacabrutideg alone compared with pirtobrutinib in pa…

Birmingham, United StatesEst. completion Apr 17, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.